Browsing Conference Papers (Medical Bioscience) by Author "Africa, Charlene Wilma Joyce"

Now showing items 1-5 of 5

    • Candida species carriage in diabetic patients in Misrata, Libya 

      Esmaio, Mustafa Hassan Mustafa; Abrantes, Pedro Miguel dos Santos; Africa, Charlene Wilma Joyce (Medpharm Publications, 2017)
      Background: There is a paucity of studies describing the prevalence and antimicrobial profiles of Candida in Libya. Limited treatment choices in the antifungal armamentarium in public healthcare settings in Africa require ...

    • Colistin, Carbapenem and Cephalosporin-resistant Klebsiella pneumoniae reported from Misrata, Libya 

      Shallouf, Mohamed; Abrantes, Pedro Miguel dos Santos; Fielding, Burtram Clinton; Africa, Charlene Wilma Joyce (Medpharm Publications, 2017)
      Background: National surveillance of antimicrobial resistance has become a mandatory approach to control the spread of antimicrobial resistance and for the establishment of antibiotic treatment guidelines. In this study, ...

    • Real-time assessment of Candida biofilm disruption by Galenia africana 

      Stuurman, Keith; Abrantes, Pedro Miguel dos Santos; Klaasen, Jeremy; Africa, Charlene Wilma Joyce (2022-05-25)
      Candida species often cause opportunistic infections in immunocompromised patients and are able to form highly structured biofilms that protect the yeast cells from the external environment and the action of antimicrobials. ...

    • Real-time assessment of Candida biofilm formation 

      Abrantes, Pedro Miguel dos Santos; Behardien, Kauthar; Africa, Charlene Wilma Joyce (Elsevier, 2021-09)
      Background: Candida infections are responsible for increased morbidity and mortality in immunocompromised patients, particularly when the Candida biofilm is composed of drug-resistant species. Although the biofilm formation ...

    • Vitek characterisation of type 2 diabetes-associated Candida species 

      Esmaio, Mustafa Hassan Mustafa; Abrantes, Pedro Miguel dos Santos; Africa, Charlene Wilma Joyce (Elsevier, 2017)
      Background: Type 2 diabetes mellitus (T2DM) predisposes patients to opportunistic infections, such as invasive candidiasis. Treatment of candidiasis is challenged by the emerging resistance of Candida species. In this ...